Connect with us


New drug candidate to fight COVID-19 – The West Australian

Former Australian of the Year Professor Ian Frazer is leading development of a new immunotherapy drug that could treat life-threatening COVID-19 complications.



Article feature image

A drug described as potential new immunotherapy for COVID-19 will enter a clinical trial in the USA led by former Australian of the Year Professor Ian Frazer.
Developed by Brisbane and Seattle-based company, Implicit Bioscience, the drug IC14 will this week be tested in COVID-19 patients in 10-15 hospitals across the United States.
The new drug, for which Prof Frazer is the clinical immunologist and chief scientific officer, will treat immune responses to COVID-19 and its health complications.

Click here to view the original article.

Continue Reading

You might also like ...

Article feature image
Damage to the white matter is more predictive of cognitive impairment after brain injury – News-Medical.Net
Article feature image
Targeted therapies could exploit unique metabolic features of pancreatic cancer cells – News-Medical.Net